Polypill for Prevention of Cardiomyopathy

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT06143566

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06143566
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06143566. Randomized; no masking; primary purpose treatment. Start 2024-03-11 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Polypill for Prevention of Cardiomyopathy
Acronym
PolyPreventHF
Intervention (Drug)
Polypill
Intervention (Drug)
Combined prescription of the individual medications
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct06143566
Content hash
1244a4876f1ab64043d65526a58040ec9b645adbe84db482fe91027560ca6108